Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Apr 21 2021

Full Issue

Nevada One Step Closer To Easing Rules On Birth Control Prescriptions

Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.

AP: Nevada Senate Passes Proposal To Expand Birth Control Access

The Nevada state Senate on Monday voted unanimously in favor of a proposal to allow pharmacists to provide patients birth control without authorization from a doctor or health care provider with a traditional prescription pad. Senate Bill 190 proposes expanding the scope of services that pharmacists can provide to ensure people who cannot access doctor’s appointments because of costs or the state’s physician shortage can obtain hormonal contraceptives including pills, patches or rings directly from a pharmacy. (Metz, 4/20)

Dayton Daily News: Ohio Medicaid Adds PBM ‘Checks And Balances’ To $3.5B Prescription Program

A new contractor has been hired as part of a state effort to introduce “an unparalleled level of financial checks and balances” to the $3.5 billion prescription benefit program with Ohio Medicaid. This follows years of controversy over how private companies manage billions in drug spending on behalf of the state. (Schroeder, 4/15)

Devils Lake Journal: ND Lawmakers Make Key Decisions On Drug-Cost Bills

Those calling for sweeping action to reduce prescription-drug prices in North Dakota saw mixed results this legislative session. One proposal was a price transparency bill. When a planned price hike exceeds 10% over one year or 40% over five years, the drug manufacturer would be required to explain why. The bill has cleared hurdles in both chambers and is expected to go to the governor. (Moen, 4/16)

Main Street Clarksville: Tennessee Patients Struggle With Rising Prescription Drug Costs 

Under current law, Tennessee patients can be required to use certain pharmacies to fill their prescriptions, but a bill in the state legislature could change that. On March 30, the House Insurance Subcommittee approved a bill to ban so-called patient steering and increase transparency and regulation of drug pricing. Davidson County resident Eben Cathey said his wife, who has ALS, recently was told she almost certainly would need to change pharmacies and potentially switch providers after enrolling in Medicare. (Ramlagen, 4/17)

Greensboro.Com: People's Pharmacy: How Authorized Generic Drugs Save Money 

People go to outlet malls because they can often save anywhere from 25% to 65% (Consumer Reports, Dec. 9, 2018). The average discount, according to CR, is 38%. The appeal is brand name quality at a lower price. Most people don’t realize that they can get a similar value for their prescription medicines if they seek authorized generic (AG) drugs. This option is rarely mentioned by pharmacists, physicians or insurance companies, but it can represent huge savings for brand-name quality. (Graedon and Graedon, 4/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF